Patents by Inventor Cuifang Lin

Cuifang Lin has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Tyrosine derivatives substituted by N-arylacryloyl as agonists of hPPAR alpha and/or hPPAR gamma
    Patent number: 7781468
    Abstract: The present invention relates to a compound of formula I, racemates, optically active isomers, or pharmaceutically acceptable salts or solvates thereof, and a pharmaceutical composition comprising the compound, the various radicals in the formula I are the same as defined in the claims.
    Type: Grant
    Filed: March 2, 2005
    Date of Patent: August 24, 2010
    Assignee: Beijing Molecule Science Technology Co., Ltd.
    Inventors: Song Li, Xinbo Zhou, Lili Wang, Cheng Xu, Chengmai Ruan, Cuifang Lin, Junhai Xiao, Zhibing Zhen, Hongying Liu, Yunde Xie, Zhong Wu, Hao Cui
  • Substituted ?-piperazinyl phenylpropionic acid derivatives as hPPAR ? and/or hPPAR ? agonists
    Patent number: 7544687
    Abstract: The present invention relates to a compound of formula I, racemates, optically active isomers, or pharmaceutically acceptable salts or solvates thereof, and a pharmaceutical composition comprising the compound, the various radicals in the formula I are the same as defined in the claims. The present invention also relates to a process for preparing the compound of formula I and use of said compound in the preparation of a medicament for the treatment of hyperglycemia, dyslipidemia, type II diabetes mellitus including associated diabetic dyslipidemia.
    Type: Grant
    Filed: February 2, 2005
    Date of Patent: June 9, 2009
    Assignee: Beijing Molecule Science and Technology Co., Ltd
    Inventors: Song Li, Xinbo Zhou, Lili Wang, Cheng Xu, Chengmai Ruan, Cuifang Lin, Junhai Xiao, Zhibing Zheng, Hongying Liu, Yunde Xie, Wu Zhong, Hao Cui
  • Tyrosine Derivatives Substituted By N-Arylacryloyl as Agonists of Hppar Alpha and/or Hppar Gamma
    Publication number: 20080300286
    Abstract: The present invention relates to a compound of formula I, racemates, optically active isomers, or pharmaceutically acceptable salts or solvates thereof, and a pharmaceutical composition comprising the compound, the various radicals in the formula I are the same as defined in the claims.
    Type: Application
    Filed: March 2, 2005
    Publication date: December 4, 2008
    Inventors: Song Li, Xinbo Zhou, Lili Wang, Cheng Xu, Chengrnai Ruan, Cuifang Lin, Junhai Xiao, Zhibing Zhen, Hongying Liu, Yunde Xie, Zhong Wu, Hao Cui
  • Substitued A-Piperazingly Phenylpropionic Acid Derivatives As Hppar Alpha And/Or Hppar Gamma Agonists
    Publication number: 20070259883
    Abstract: The present invention relates to a compound of formula I, racemates, optically active isomers, or pharmaceutically acceptable salts or solvates thereof, and a pharmaceutical composition comprising the compound, the various radicals in the formula I are the same as defined in the claims.
    Type: Application
    Filed: February 2, 2005
    Publication date: November 8, 2007
    Applicant: BEIJING MOLECULE SCIENCE AND TECHNOLOGY CO., LTD.
    Inventors: Song Li, Xinbo Zhou, Lili Wang, Cheng Xu, Chengmai Ruan, Cuifang Lin, Junhai Xiao, Zhibing Zheng, Hongying Liu, Yunde Xie, Wu Zhong, Hao Cui